Clinical Trials
2 trialsNCT05275504 2022-06-09
Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
TransThera Sciences (Nanjing), Inc.
Phase 1 Unknown
NCT03642496 2018-08-23
Clinical Study of ET019002-T Cell Therapy for Refractory/Relapsed B-Cell Malignancies
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1 Unknown